PreveCeutical Medical Inc. (CSE:PREV)
Canada · Delayed Price · Currency is CAD 0.0200
-0.0050 (-20.00%)
Feb 9, 2026, 11:37 AM EST
PreveCeutical Medical Market Cap
PreveCeutical Medical has a market cap or net worth of CAD 11.96 million as of February 9, 2026. Its market cap has increased by 10.43% in one year.
Market Cap
11.96M
Enterprise Value
16.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since July 14, 2017, PreveCeutical Medical's market cap has increased from 6.06M to 11.96M, an increase of 97.34%. That is a compound annual growth rate of 8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 14.95M | - |
| Dec 31, 2025 | 14.95M | 10.43% |
| Dec 31, 2024 | 13.54M | 1.20% |
| Dec 29, 2023 | 13.38M | - |
| Dec 30, 2022 | 13.38M | 4.61% |
| Dec 29, 2021 | 12.79M | -13.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Dose Therapeutics | 19.60M |
| Hemostemix | 17.57M |
| Britannia Life Sciences | 16.23M |
| Innovotech | 14.04M |
| Lobe Sciences | 13.47M |
| Pharmala Biotech Holdings | 10.89M |
| Glow Lifetech | 9.98M |
| Cytophage Technologies | 9.81M |